返回
摘要
En 中文
Halofuginone is an analog of febrifugine-an alkaloid originally isolated from the plant Dichroa febrifuga. During recent years, halofuginone has attracted much attention because of its wide range of beneficial biological activities, which encompass malaria, cancer, and fibrosis-related and autoimmune diseases. At present two modes of halofuginone actions have been described: (1) Inhibition of Smad3 phosphorylation downstream of the TGF beta signaling pathway results in inhibition of fibroblasts-to-myofibroblasts transition and fibrosis. (2) Inhibition of prolyl-tRNA synthetase (ProRS) activity in the blood stage of malaria and inhibition of Th17 cell differentiation thereby inhibiting inflammation and the autoimmune reaction by activation of the amino acid starvation and integrated stress responses. This review deals with the history and origin of this natural product, its synthesis, its known modes of action, and it's various biological activities in pre-clinical animal models and in humans.
Keyword:
malaria
fibrosis
inflammation
autoimmunity
Th-17
apoptosis
AI总结
对已上传原文的论文进行重点信息的提取,主要内容包括:简要概述、研究摘要、背景介绍、关键亮点、图文解析、展望与总结。
期刊
IF:
4.6
论文数:
6.5W
被引数:
23.7W
机构
引用论文
Nature and culture of finger counting: Diversity and representational effects of an embodied cognitive tool
Cognition
IF0
Comparative efficacy of anticoccidials under the conditions of commercial broiler production and in battery trials在商业肉鸡生产和电池试验条件下抗球虫的比较功效
Halofuginone - An inhibitor of collagen type I synthesis - Prevents postoperative formation of abdominal adhesions
ANNALS OF SURGERY
IF6.4
Myofibroblasts in pulmonary and brain metastases of Alveolar Soft-part Sarcoma: A novel target for treatment?
NEOPLASIA
IF7.7

